Skip to content

Dare Bioscience, Inc.: 10-Q filed 2022-08-09

What Dare Bioscience, Inc. reported in its quarterly report filed 2022-08-09 (fiscal Q2 2022): 39 published measures, 113 facts as tagged in accession 0001401914-22-000075.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-09
Fiscal period
fiscal Q2 2022
Accession
0001401914-22-000075 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Dare Bioscience, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3051,394,340USD
At 2021-12-3155,807,177USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-3018,360,881USD
At 2021-12-3117,052,856USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-3033,033,459USD
At 2022-03-3130,878,910USD
At 2021-12-3138,754,321USD
At 2021-06-307,744,004USD
At 2021-03-313,258,233USD
At 2020-12-31-1,151,733USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3032,070,612USD
At 2021-12-3151,674,087USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30413,998USD91
2022-01-01 to 2022-06-30-7,984,672USD181
2022-01-01 to 2022-03-31-8,398,670USD90
2021-04-01 to 2021-06-30-9,162,751USD91
2021-01-01 to 2021-06-30-16,486,395USD181
2021-01-01 to 2021-03-31-7,323,644USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-20,791,986USD181
2021-01-01 to 2021-06-30-20,168,469USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-06-305,369USD181
2021-01-01 to 2021-06-300USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-04-01 to 2022-06-3010,000,000USD91
2022-01-01 to 2022-06-3010,000,000USD181
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-04-01 to 2022-06-3010,000,000USD91
2022-01-01 to 2022-06-3010,000,000USD181
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,338,899USD181
2021-01-01 to 2021-06-3024,626,464USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-5,369USD181
2021-01-01 to 2021-06-300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-118,111,574USD
At 2021-12-31-110,126,902USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3084,682,765shares91
2022-01-01 to 2022-06-3084,682,765shares181
2021-04-01 to 2021-06-3050,436,593shares91
2021-01-01 to 2021-06-3047,485,980shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-04-01 to 2022-06-3085,369,424shares91
2022-01-01 to 2022-06-3084,682,765shares181
2021-04-01 to 2021-06-3050,436,593shares91
2021-01-01 to 2021-06-3047,485,980shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-300USD/shares91
2022-01-01 to 2022-06-30-0.1USD/shares181
2021-04-01 to 2021-06-30-0.18USD/shares91
2021-01-01 to 2021-06-30-0.35USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-04-01 to 2022-06-300USD/shares91
2022-01-01 to 2022-06-30-0.1USD/shares181
2021-04-01 to 2021-06-30-0.18USD/shares91
2021-01-01 to 2021-06-30-0.35USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-3020,864USD
At 2021-12-3126,041USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,069,930USD181
2021-01-01 to 2021-06-30771,389USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30384,322USD91
2022-01-01 to 2022-06-30-8,016,128USD181
2021-04-01 to 2021-06-30-9,162,926USD91
2021-01-01 to 2021-06-30-16,856,460USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-3050,112,631USD
At 2021-12-3155,296,016USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-3016,536,936USD
At 2021-12-3116,052,856USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-301,114,228USD
At 2021-12-312,103,083USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-06-3010,000,000USD
At 2021-12-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-309,615,678USD91
2022-01-01 to 2022-06-3018,016,128USD181
2021-04-01 to 2021-06-309,162,926USD91
2021-01-01 to 2021-06-3016,856,460USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-306,797,784USD91
2022-01-01 to 2022-06-3012,603,247USD181
2021-04-01 to 2021-06-307,340,289USD91
2021-01-01 to 2021-06-3013,068,495USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3083,944,119shares
At 2021-12-3183,944,119shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-06-3032,070,612USD
At 2021-12-3151,674,087USD
At 2021-06-309,111,741USD
At 2020-12-314,669,467USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-06-30-299,992USD
At 2021-12-31-154,973USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-06-301,148,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-06-301,260,845USD
At 2021-12-31485,120USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-306,347,367USD
At 2021-12-313,136,244USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-04-01 to 2022-06-30278,129USD91
2022-01-01 to 2022-06-30-8,129,691USD181
2021-04-01 to 2021-06-30-9,171,631USD91
2021-01-01 to 2021-06-30-16,502,116USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-302,792,894USD91
2022-01-01 to 2022-06-305,362,881USD181
2021-04-01 to 2021-06-301,797,637USD91
2021-01-01 to 2021-06-303,737,965USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-01-01 to 2022-06-3010,546USD181
2021-01-01 to 2021-06-3013,023USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-04-01 to 2022-06-3029,676USD91
2022-01-01 to 2022-06-3031,456USD181
2021-04-01 to 2021-06-30175USD91
2021-01-01 to 2021-06-30178USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,300,000USD181
2021-01-01 to 2021-06-307,000,000USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-04-01 to 2022-06-3080,000USD91
2022-01-01 to 2022-06-30203,000USD181
2021-04-01 to 2021-06-30114,000USD91
2021-01-01 to 2021-06-30226,000USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-3010,000,000USD181
2021-01-01 to 2021-06-300USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-988,855USD181
2021-01-01 to 2021-06-30-805,291USD181

Inspect the source

Entity
Dare Bioscience, Inc. / CIK 0001401914
Captured
2026-09-20T08:00:44.110Z
SEC response SHA-256
1a9e5d436251c8650231f065c4c293fc1bb2b6e8877619128801af21ceea9ac3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001401914.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))